Moderna’s Suit Against Pfizer/BioNTech Is About More Than Money

 
• By Alaric DeArment

Moderna is seeking financial compensation for Comirnaty in its patent infringement suit, but it seems especially keen to assert IP rights over what could become an even more valuable platform technology.

Moderna is filing a patent infringement suit against Pfizer/BioNTech over technology used in its Spikevax vaccine • Source: Shutterstock

More from R&D

More from Scrip